Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Talis Biomedical Corp (NQ: TLIS )

8.540 UNCHANGED
Streaming Delayed Price Updated: 3:50 PM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 8.540
Bid (Size) 8.460 (1)
Ask (Size) 8.880 (3)
Prev. Close 8.540
Today's Range 8.540 - 8.540
52wk Range 4.350 - 9.600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024
Talis Biomedical just reported results for the first quarter of 2024. 
Via InvestorPlace
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+6.22%
+6.22%
1 Month
-0.70%
-0.70%
3 Month
+1.06%
+1.06%
6 Month
+6.62%
+6.62%
1 Year
+16.19%
+16.19%

More News

Read More
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
Via InvestorPlace
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
BTIG Maintains Sell Rating for Talis Biomedical: Here's What You Need To Know
Via Benzinga
A Preview Of Talis Biomedical's Earnings
Via Benzinga
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Talis Biomedical (TLIS) Stock Is Exploding Higher
Via Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
From Talis Biomedical Corporation
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
7 Small-Cap Stocks to Sell in August Before They Crash and Burn
Via InvestorPlace
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
From Talis Biomedical Corporation
Via GlobeNewswire
Earnings Scheduled For August 10, 2023
Via Benzinga
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
From Talis Biomedical Corporation
Via GlobeNewswire
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
From Talis Biomedical Corporation
Via GlobeNewswire
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
From Talis Biomedical Corporation
Via GlobeNewswire
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Talis Biomedical Corporation
Via GlobeNewswire
Talis Biomedical Announces 1-for-15 Reverse Stock Split
From Talis Biomedical Corporation
Via GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director
From Talis Biomedical Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.